Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
14.44
-0.25 (-1.70%)
At close: Mar 24, 2026, 4:00 PM EDT
14.16
-0.28 (-1.94%)
After-hours: Mar 24, 2026, 4:44 PM EDT
Nurix Therapeutics Market Cap
Nurix Therapeutics has a market cap or net worth of $1.49 billion as of March 24, 2026. Its market cap has increased by 41.19% in one year.
Market Cap
1.49B
Enterprise Value
947.84M
1-Year Change
41.19%
Ranking
Category
Stock Price
$14.44
Market Cap Chart
Since July 24, 2020, Nurix Therapeutics's market cap has increased from $704.09M to $1.49B, an increase of 110.92%. That is a compound annual growth rate of 14.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 1.51B | -21.44% |
| Dec 31, 2025 | 1.92B | 44.09% |
| Dec 31, 2024 | 1.33B | 166.61% |
| Dec 29, 2023 | 500.56M | -3.31% |
| Dec 30, 2022 | 517.68M | -59.92% |
| Dec 31, 2021 | 1.29B | 1.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innoviva | 1.62B |
| Harmony Biosciences Holdings | 1.60B |
| Generate Biomedicines | 1.60B |
| Novavax | 1.58B |
| Intellia Therapeutics | 1.55B |
| Immunocore Holdings | 1.54B |
| Nuvation Bio | 1.51B |
| Iovance Biotherapeutics | 1.50B |